Publications by authors named "Gitika Panicker"

Claim this Profile
L
Long term immunogenicity of two doses of the quadrivalent HPV vaccine and the effect of an additional dose given five years post-primary vaccination.
Chantal Sauvageau, Iulia Gabriela Ionescu, Manale Ouakki, Gitika Panicker, Elizabeth R Unger

Vaccine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response after one dose of HPV vaccine among girls and boys and the impact of a second dose given after 3 or more years.
Nicolai Guzun, Manale Ouakki, Gitika Panicker, Iulia Gabriela Ionescu, Marie-Hélène Mayrand

Vaccine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and duration of antibodies after vaccination with a two-dose series of the nine-valent human papillomavirus vaccine among Alaska Native children: a prospective cohort study.
Jonathan Steinberg, Gitika Panicker, Elizabeth R Unger, Ian Blake, Rayleen M Lewis

BMC Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community intervention of a single-dose or 2-dose regimen of bivalent human papillomavirus vaccine in schoolgirls in Thailand: vaccine effectiveness 2 years and 4 years after vaccination.
Suchada Jiamsiri, Chulwoo Rhee, Hyeon Seon Ahn, Hyeong-Won Seo, Worrawan Klinsupa, Gitika Panicker

J Natl Cancer Inst Monogr· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58.
Troy J Kemp, Gitika Panicker, Carina Eklund, Jianhui Nie, Youchun Wang

NPJ Vaccines· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of quadrivalent human papillomavirus vaccine among Alaska Native children aged 9-14 years at 5 years after vaccination.
Bionca M Davis, Ian Blake, Gitika Panicker, Elissa Meites, Gail Thompson

Vaccine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of 2 or 3 Doses of 9vHPV Vaccine in U.S. Female Individuals 15 to 26 Years of Age.
Abbey B Berenson, Gitika Panicker, Elizabeth R Unger, Richard E Rupp, Yong-Fang Kuo

NEJM Evid· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine.
Neerja Bhatla, Richard Muwonge, Sylla G Malvi, Smita Joshi, Usha Rani Reddy Poli, Gitika Panicker

Hum Vaccin Immunother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up of humoral immune response after HPV vaccination using first-void urine: A longitudinal cohort study.
Laura Téblick, Jade Pattyn, Severien Van Keer, Annemie De Smet, Ilse De Coster, Gitika Panicker

J Med Virol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination.
Smita Joshi, Devasena Anantharaman, Richard Muwonge, Neerja Bhatla, Gitika Panicker

Vaccine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route.
Trinh Phuong Vo, Gitika Panicker, Kimberly Braz-Gomes, Ashwin C Parenky, Ira Rajbhandari

Pharmaceuticals (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Papillomavirus Oral- and Sero- Positivity in Fanconi Anemia.
Sharon L Sauter, Xue Zhang, Lindsey Romick-Rosendale, Susanne I Wells, Kasiani C Myers, Gitika Panicker

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of a VLP-based and GST-L1-based multiplex immunoassay to detect vaccine-induced HPV-specific antibodies in first-void urine.
Jade Pattyn, Gitika Panicker, Martina Willhauck-Fleckenstein, Severien Van Keer, Laura Téblick

J Med Virol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective cohort study of immunogenicity of quadrivalent human papillomavirus vaccination among Alaska Native Children, Alaska, United States.
Michael G Bruce, Elissa Meites, Lisa Bulkow, Gitika Panicker, Debby Hurlburt

Vaccine· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity.
Allison M Brady, Emmanuel B Walter, Lauri E Markowitz, Elizabeth R Unger, Gitika Panicker

Hum Vaccin Immunother· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines.
Sabrina H Tsang, Partha Basu, Noemi Bender, Rolando Herrero, Troy J Kemp, Gitika Panicker

Vaccine· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure.
Lilin Lai, Kevin Ault, Nadine Rouphael, Allison Beck, Briyana Domjahn, Gitika Panicker

Vaccines (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long intervals between two doses of HPV vaccines and magnitude of the immune response: a analysis of two clinical trials.
Vladimir Gilca, Chantal Sauvageau, Gitika Panicker, Gaston De Serres, John Schiller

Hum Vaccin Immunother· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials.
Chantal Sauvageau, Gitika Panicker, Elizabeth R Unger, Gaston De Serres, John Schiller

Hum Vaccin Immunother· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chlamydia Trachomatis and Human Papillomavirus Serostatus in Puerto Rican Women.
Maira A Castañeda-Avila, Erick Suárez-Pérez, Raúl Bernabe-Dones, Elizabeth R Unger, Gitika Panicker

P R Health Sci J· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later - an exploratory study.
Vladimir Gilca, Chantal Sauvageau, Gitika Panicker, Gaston De Serres, Manale Ouakki

Hum Vaccin Immunother· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transgender Women Have Higher Human Papillomavirus Prevalence Than Men Who Have Sex With Men-Two U.S. Cities, 2012-2014.
Vidisha Singh, Beau Gratzer, Pamina M Gorbach, Richard A Crosby, Gitika Panicker

Sex Transm Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroprevalence of Human Papillomavirus 6/11/16/18 Among Self-identified Gay/Bisexual Men Who Have Sex With Men, Men Who Have Sex With Women, and Females, United States, 2003-2010.
Rayleen M Lewis, Lauri E Markowitz, Gitika Panicker, Elizabeth R Unger

Clin Infect Dis· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine - A randomized clinical trial.
Vladimir Gilca, Chantal Sauvageau, Gitika Panicker, Gaston De Serres, Manale Ouakki

Vaccine· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroprevalence of Human Papillomavirus (HPV) Type 6, 11, 16, 18, by Anatomic Site of HPV Infection, in Women Aged 16-64 Years living in the Metropolitan Area of San Juan, Puerto Rico.
Aixa M Pérez-Caraballo, Erick Suarez, Elizabeth R Unger, Joel M Palefsky, Gitika Panicker

P R Health Sci J· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis